4F-4PP

4F 4PP

4F-4PP

4F-4PP
Clinical data
Other names4F4PP; FPPO; 4-PBFBP; FBP; 4-(4-Fluorobenzoyl)-1-(4-phenylbutyl)piperidine; N-(4-Phenylbutyl)-4-(4-fluorobenzoyl)piperidine
Drug classSerotonin 5-HT2A receptor antagonist
ATC code
  • None
Identifiers
  • (4-fluorophenyl)-[1-(4-phenylbutyl)piperidin-4-yl]methanone
CAS Number
PubChem CID
ChemSpider
ChEBI
ChEMBL
Chemical and physical data
FormulaC22H26FNO
Molar mass339.454 g·mol−1
3D model (JSmol)
  • C1CN(CCC1C(=O)C2=CC=C(C=C2)F)CCCCC3=CC=CC=C3
  • InChI=1S/C22H26FNO/c23-21-11-9-19(10-12-21)22(25)20-13-16-24(17-14-20)15-5-4-8-18-6-2-1-3-7-18/h1-3,6-7,9-12,20H,4-5,8,13-17H2
  • Key:FTJXZACAQRDRNT-UHFFFAOYSA-N

4F-4PP, or 4F4PP, also known as 4-(4-fluorobenzoyl)-1-(4-phenylbutyl)piperidine, is a selective serotonin 5-HT2A receptor antagonist which is used in scientific research.[1][2][3]

Pharmacology

4F-4PP shows high affinity for the serotonin 5-HT2A receptor (Ki = 5.3 nM) and 120-fold lower affinity for the serotonin 5-HT2C receptor (Ki = 620 nM).[1][3] For comparison, ketanserin showed only 14-fold higher affinity for the serotonin 5-HT2A receptor over the serotonin 5-HT2C receptor in the same study.[1] In a functional assay, 4F-4PP was 204-fold more potent as a serotonin 5-HT2A receptor antagonist than as a serotonin 5-HT2C receptor antagonist.[2] The drug does not appear to block the serotonin 5-HT2B receptor.[4] It showed limited and non-significant effects on the oxytocin and vasopressin secretion induced by the serotonin 5-HT2A and 5-HT2C receptor agonist and serotonergic psychedelic DOI in rodents.[3]

Chemistry

Analogues

A radiolabeled isotopologue for use in positron emission tomography (PET) imaging has been described.[5]

History

4F-4PP first described in the scientific literature by 1992.[1] It is an analogue of and was derived via structural modification of ketanserin.[1]

See also

References

  1. ^ a b c d e Herndon JL, Ismaiel A, Ingher SP, Teitler M, Glennon RA (December 1992). "Ketanserin analogues: structure-affinity relationships for 5-HT2 and 5-HT1C serotonin receptor binding". Journal of Medicinal Chemistry. 35 (26): 4903–4910. doi:10.1021/jm00104a017. PMID 1479590.
  2. ^ a b Acuña-Castillo C, Villalobos C, Moya PR, Sáez P, Cassels BK, Huidobro-Toro JP (June 2002). "Differences in potency and efficacy of a series of phenylisopropylamine/phenylethylamine pairs at 5-HT(2A) and 5-HT(2C) receptors". British Journal of Pharmacology. 136 (4): 510–519. doi:10.1038/sj.bjp.0704747. PMC 1573376. PMID 12055129.
  3. ^ a b c Jørgensen H, Riis M, Knigge U, Kjaer A, Warberg J (March 2003). "Serotonin receptors involved in vasopressin and oxytocin secretion". Journal of Neuroendocrinology. 15 (3): 242–249. doi:10.1046/j.1365-2826.2003.00978.x. PMID 12588512. Serotonin (5-HT), 5-HT agonists, the 5-HT precursor 5-hydroxytryptophan, 5-HT-releasers and -reuptake inhibitors stimulate the release of vasopressin and oxytocin. We investigated the involvement of 5-HT receptors in the serotonergic regulation of vasopressin and oxytocin secretion. Vasopressin and oxytocin secretion was stimulated by [...] the 5-HT2A+2C agonist DOI, [...] The 5-HT2A antagonist 4-(4-flourobenzoyl)-1-(4-phenylbutyl)-piperidine oxalate had no effect on DOI-induced hormone response. [...] We conclude that 5-HT-induced vasopressin secretion primarily is mediated via 5-HT2C, 5-HT4 and 5-HT7 receptors, whereas 5-HT2A, 5-HT3 and 5-HT5A receptors seem to be of minor importance. 5-HT-induced oxytocin secretion involves 5-HT1A, 5-HT2C and 5-HT4 receptors; in addition an involvement of 5-HT1B, 5-HT5A and 5-HT7 receptors seems likely, whereas 5-HT2A and 5-HT3 receptors seem to be less important. [...] The following 5-HT receptor antagonists were used: [...] the 5-HT2A antagonist 4-(4- flourobenzoyl)-1-(4-phenylbutyl)-piperidine oxalate (FBP); [...] FIG. 4. Vasopressin (A; AVP) or oxytocin (B; OT) response to: (I) the 5-HT2Aþ2C agonist DOI (20 nmol) after pretreatment with the 5-HT2A antagonist 4-(4- flourobenzoyl)-1-(4-phenylbutyl)-piperidine oxalate (FBP; 1, 10 or 100 nmol), [...] TABLE 2. Receptor Affinities for the 5-HT Antagonists Expressed as pKi Values. [...] FBP = 4-(4-flourobenzoyl)- 1-(4-phenylbutyl)-piperidine oxalate.
  4. ^ Sandén N, Thorlin T, Blomstrand F, Persson PA, Hansson E (April 2000). "5-Hydroxytryptamine2B receptors stimulate Ca2+ increases in cultured astrocytes from three different brain regions". Neurochemistry International. 36 (4–5): 427–434. doi:10.1016/s0197-0186(99)00134-5. PMID 10733010.
  5. ^ Hashimoto K, Hatano K, Minabe Y, Iyo M, Taniguchi M, Hoshino O, et al. (1998). "Radiosynthesis of [18F]N-(4-phenylbutyl)-4-(4-fluorobenzoyl)piperidine for studying serotonin 5-HT2a receptors". Journal of Labelled Compounds and Radiopharmaceuticals. 41 (10): 941–949. doi:10.1002/(SICI)1099-1344(1998100)41:10<941::AID-JLCR151>3.0.CO;2-6.

Content Disclaimer

Informasi ini disarikan dari Wikipedia dan disajikan kembali untuk tujuan edukasi. Konten tersedia di bawah lisensi CC BY-SA 3.0. Kami tidak bertanggung jawab atas ketidakakuratan data yang bersumber dari kontribusi publik tersebut.

  1. The information displayed on this website is sourced in part or in whole from Wikipedia and has been adapted for the purpose of restating it. We strive to provide accurate and relevant information, however:
  2. There is no guarantee of absolute accuracy. Wikipedia is an open, collaborative project that can be edited by anyone, so information is subject to change.
  3. It is not intended to constitute professional advice. The content displayed is for informational and educational purposes only. For important decisions (e.g., medical, legal, or financial), please consult a professional.
  4. Content copyright. Wikipedia is licensed under the Creative Commons Attribution-ShareAlike License (CC BY-SA). This means that content may be reused with appropriate attribution and shared under a similar license.
  5. Responsible use. Any risk arising from the use of information from this website is entirely the responsibility of the user.